|
French target trial using obs data of HCQ vs not in SARS-CoV-2 infection
|
|
10
|
3611
|
August 5, 2026
|
|
Determining post-test probability of Covid-19
|
|
38
|
42713
|
January 12, 2024
|
|
Is it the numerator or denominator which explains variations of a ratio?
|
|
1
|
1888
|
May 11, 2022
|
|
First RCT of Lopinavir–Ritonavir on SARS-CoV2
|
|
38
|
19932
|
October 8, 2021
|
|
How to update a prognostic model of COVID-19 for the effect of vaccination
|
|
3
|
2730
|
August 7, 2021
|
|
Fully sequential Bayesian clinical trial design for in-hospital treatment of COVID-19
|
|
23
|
13053
|
June 7, 2021
|
|
Corticosteroid Timing for COVD-19
|
|
3
|
3618
|
January 17, 2021
|
|
Covid-19 vaccine Phase 3 trials
|
|
2
|
4094
|
November 25, 2020
|
|
Observational Study of Convalescent Plasma and FDA Response
|
|
17
|
10552
|
September 1, 2020
|
|
A JAMA paper on School Closing Timing and Covid-19 prevalence and mortality
|
|
1
|
3174
|
August 7, 2020
|
|
Open-label RCT of triple combination (LPV/r, Ribavirin, Interferon) on SARS-CoV2
|
|
1
|
3325
|
May 15, 2020
|
|
SARS-CoV2 Testing: How Does PPV Factor into Discussion of Test Performance?
|
|
4
|
5087
|
May 12, 2020
|
|
COVID-19 Research Methods Resources
|
|
10
|
12621
|
May 4, 2020
|
|
Illness Severity among Non-COVID patients
|
|
11
|
9098
|
April 19, 2020
|
|
Visualization for Benefit of COVID-19 Testing for Decreasing Provider Risk During Intubation
|
|
1
|
2721
|
April 2, 2020
|
|
Power calculations for cluster-RCT in hospital infection control (PPE for Covid19)
|
|
6
|
6051
|
April 1, 2020
|
|
COVID-19 Death Prediction Modeling Strategy Discussion
|
|
0
|
3082
|
March 29, 2020
|
|
"Impressive" or "anecdotal"? Hydroxychloroquine + Azithromycin vs COVID-19 preprint
|
|
4
|
4608
|
March 22, 2020
|
|
Imperial College Paper on Interventions to Reduce COVID-19 Population Level Impact
|
|
0
|
3636
|
March 19, 2020
|